Sort
78,016 grants matching “breast cancer”
Oxidative activation of the dietary cancer chemopreventive agent curcumin
$522,897Claus Schneider · Vanderbilt University · R01 · FY2016 · AT
Proprietary drug to treat radiodermatitis
$522,893Christian Young · Allander Biotechnologies, Inc. · R44 · FY2021 · AR
4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN): A Phase II Clinica
$522,886Lee Roy Morgan · Dekk-Tec, Inc. · R44 · FY2014 · CA
Integrated Biochip Sensors for Detection of Cancer
$522,787Rashid Bashir · University Of Illinois At Urbana-Champaign · R01 · FY2009 · CA
CORE--MOLECULAR AND CELLULAR PROFILING
$522,777Joe W. Gray · University Of Calif-Lawrenc Berkeley Lab · U54 · FY2007 · CA
CGEMS
$522,757Robert Hoover · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA
PET Imaging of Glutamine Metabolism and Glutamate Transport to Guide Metabolically Targeted Therapy in Triple-Negative Breast Cancer
$522,750David A Mankoff · University Of Pennsylvania · R01 · FY2025 · CA
Integrated Biochip Sensors for Detection of Cancer
$522,748Rashid Bashir · University Of Illinois At Urbana-Champaign · R01 · FY2010 · CA
Mechanical regulation of the microenvironmental niche in skin tumorigenesis
$522,691Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Polymorphisms of INS/IGF Signal Pathways &Female Cancer
$522,624Albert Einstein Col Of Med Yeshiva Univ · R01 · FY2004 · CA
SAN JUAN MB COMMUNITY CLINICAL ONCOLOGY PROGRAM
$522,603San Juan City Hospital · U10 · FY2003 · CA
Patient Navigation 2.0: Addressing the Challenge of Scaling Navigation through Checklist-based Implementation
$522,596Melissa A. Simon · Northwestern University At Chicago · R01 · FY2022 · CA
Cell Cycle/Apoptosis Gene Variants and Breast Cancer Risk
$522,557Qiuyin Cai · Vanderbilt University · R01 · FY2009 · CA
Characterization and modeling of m6A RNA methylation in cancer
$522,531Han Liang · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Discovery and validation of early molecular breast cancer risk markers in benign breast disease
$522,498Christopher B Umbricht · Johns Hopkins University · R01 · FY2020 · CA
Epidemiology of Cancer in a Cohort of Older Women
$522,496Aaron R Folsom · University Of Minnesota · R01 · FY2008 · CA
Developing PARP-1 PET with companion tissue assay as a precision tool to guide PARPi therapy
$522,486Elizabeth McDonald · University Of Pennsylvania · R37 · FY2024 · CA
Oncogenic Met Signaling in Urologic Malignancies
$522,479Donald Bottaro · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Physical Activity and Lymphedema Project (PAL Trial)
$522,471University Of Minnesota Twin Cities · R01 · FY2004 · CA
Targeting posttranslational modifications of B7-H4 in carcinogenesis and therapy
$522,459Yong Wan · Northwestern University At Chicago · R01 · FY2021 · CA
Development of BRCA1-mimetic drugs for breast cancer
$522,451Eliot M Rosen · Georgetown University · R01 · FY2013 · CA
Analysis of the cellular and molecular determinants of the human breast hierarchy
$522,384Charlotte Kuperwasser · Tufts University Boston · R01 · FY2012 · HD
Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor
$522,328Hua Zhao · University Of Virginia · U01 · FY2023 · CA
DISCOIDIN DOMAIN RECEPTORS: NOVEL TARGETS IN BREAST CANCER BONE METASTASIS
$522,277Wayne State University · · FY2016 · Department of the Army
Cost-Effectiveness--Treatments--Ductal Carcinoma In Situ
$522,230University Of Rochester · R01 · FY2002 · CA